MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Dec 3, 04:59 PM (EDT)
Price
$251.34
Change
+$0.49 (+0.20%)
Capitalization
36.26B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RMD with price predictions
Nov 28, 2025

RMD's RSI Oscillator ascends from oversold territory

The RSI Oscillator for RMD moved out of oversold territory on November 17, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 24, 2025. You may want to consider a long position or call options on RMD as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RMD just turned positive on November 12, 2025. Looking at past instances where RMD's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .

RMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RMD entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.924) is normal, around the industry mean (9.233). P/E Ratio (25.423) is within average values for comparable stocks, (163.343). Projected Growth (PEG Ratio) (1.600) is also within normal values, averaging (2.548). Dividend Yield (0.009) settles around the average of (0.016) among similar stocks. P/S Ratio (6.954) is also within normal values, averaging (110.831).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

View a ticker or compare two or three
RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RMD is expected to report earnings to rise 5.88% to $2.70 per share on January 22

ResMed RMD Stock Earnings Reports
Q4'25
Est.
$2.70
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
The last earnings report on October 30 showed earnings per share of $2.55, beating the estimate of $2.52. With 154.23K shares outstanding, the current market capitalization sits at 36.26B.
A.I.Advisor
published Dividends

RMD paid dividends on September 18, 2025

ResMed RMD Stock Dividends
А dividend of $0.60 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 14, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QSPT31.670.19
+0.60%
FT Vest Nasdaq-100® Buffer ETF Sep
ASMF23.580.06
+0.26%
Virtus AlphaSimplex Managed Futures ETF
BSCR19.720.01
+0.05%
Invesco BulletShares 2027 Corp Bd ETF
PBMR30.17N/A
N/A
PGIM S&P 500 Buffer 20 ETF - Mar
GMOM33.05-0.01
-0.04%
Cambria Global Momentum ETF

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+1.01%
SOLV - RMD
51%
Loosely correlated
+0.01%
NVST - RMD
47%
Loosely correlated
-2.86%
BLCO - RMD
44%
Loosely correlated
+3.02%
ALC - RMD
40%
Loosely correlated
+1.29%
RVTY - RMD
40%
Loosely correlated
+0.33%
More

Groups containing RMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+1.01%
Pharmaceuticals
category (377 stocks)
50%
Loosely correlated
+0.67%
Pharmaceuticals: Other
category (103 stocks)
49%
Loosely correlated
+0.77%